Conferring receptors on recipient cells with extracellular vesicles for targeted drug delivery

Triple negative breast cancer (TNBC) is a heterogeneous subset of breast cancer characterized by its lack of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2), which altogether prevents TNBC from being treated effectively. For many years, the treatment par...

Descripción completa

Detalles Bibliográficos
Autores principales: Quinn, Zachary, Mao, Wenjun, Xia, Yiqiu, John, Rhea, Wan, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522541/
https://www.ncbi.nlm.nih.gov/pubmed/33024896
http://dx.doi.org/10.1016/j.bioactmat.2020.09.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522541/
https://www.ncbi.nlm.nih.gov/pubmed/33024896
http://dx.doi.org/10.1016/j.bioactmat.2020.09.016

Ejemplares similares